JOHN BAKER
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- SUMTER, SC
- NPI
- 1598922130
- Received
- $779,476 in 2,670 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 393 | $162,447 |
| 2024 | General payment | 442 | $128,582 |
| 2023 | General payment | 446 | $96,949 |
| 2022 | General payment | 386 | $112,205 |
| 2021 | General payment | 332 | $87,831 |
| 2020 | General payment | 312 | $80,624 |
| 2019 | General payment | 359 | $110,834 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 336 | $604,204 |
| Consulting Fee | 81 | $62,264 |
| Food and Beverage | 2,047 | $44,896 |
| Honoraria | 27 | $34,950 |
| Travel and Lodging | 168 | $31,582 |
| Education | 11 | $1,579 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Amgen Inc. | $75 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-30 | Amgen Inc. | $32 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-19 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-18 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-12-18 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-18 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-17 | Amgen Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-17 | Amgen Inc. | $550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-17 | Amgen Inc. | $162 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Amgen Inc. | $110 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-10 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-09 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-06 | ABBVIE INC. | $152 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-05 | Amgen Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-05 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | ABBVIE INC. | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | Amgen Inc. | $133 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-04 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | PFIZER INC. | $4 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Lundbeck LLC | $1,037 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-12-03 | Amgen Inc. | $111 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-03 | Mallinckrodt Hospital Products Inc. | $17 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-12-02 | Amgen Inc. | $104 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-01 | Teva Pharmaceuticals USA, Inc. | $460 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-28 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-28 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-26 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-24 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-19 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | Biogen, Inc. | $7 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-11-17 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-14 | Otsuka America Pharmaceutical, Inc. | $33 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Otsuka America Pharmaceutical, Inc. | $2,736 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-12 | UCB, Inc. | $28 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-11-11 | TG Therapeutics, Inc. | $465 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BRIUMVI Drug, Immunology | 2025 | |
| 2025-11-11 | TG Therapeutics, Inc. | $6 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-11-07 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $2,763 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $113 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $32 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $20 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-05 | EMD Serono, Inc. | $33 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-05 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-11-04 | PFIZER INC. | $4,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-04 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-11-04 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-11-03 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-31 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-30 | PFIZER INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-30 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-29 | UCB, Inc. | $19 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-10-29 | Celgene Corporation | $6 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-28 | Biogen, Inc. | $19 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-10-24 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-24 | Axsome Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Neurocrine BioSciences, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-23 | E.R. Squibb & Sons, L.L.C. | $267 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-23 | Neurocrine BioSciences, Inc. | $128 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-23 | Neurocrine BioSciences, Inc. | $120 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-23 | TG Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-10-22 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-22 | Biogen, Inc. | $14 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-10-22 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | Biogen, Inc. | $31 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-10-16 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-16 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-15 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | WAINUA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-10-14 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-13 | Amgen Inc. | $550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-10 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-10 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $10 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-09 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-10-08 | E.R. Squibb & Sons, L.L.C. | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-08 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-10-08 | LivaNova USA, Inc. | $16 | Food and Beverage | In-kind items and services | VNS Therapy Device, Neurology | 2025 | |
| 2025-10-07 | SK Life Science, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-03 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | PFIZER INC. | $210 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-02 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-02 | Celgene Corporation | $7 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-30 | Lundbeck LLC | $34 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-30 | Lundbeck LLC | $23 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $15 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $15 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $12 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $12 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $8 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $6 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | Lundbeck LLC | $5 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-30 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-26 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-25 | E.R. Squibb & Sons, L.L.C. | $230 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-25 | E.R. Squibb & Sons, L.L.C. | $63 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-24 | ABBVIE INC. | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-23 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-22 | PFIZER INC. | $1,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-22 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-19 | PFIZER INC. | $210 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-19 | PFIZER INC. | $33 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-19 | PFIZER INC. | $9 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-18 | Neurocrine BioSciences, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-18 | Neurocrine BioSciences, Inc. | $219 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-18 | Neurocrine BioSciences, Inc. | $133 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-18 | Neurocrine BioSciences, Inc. | $123 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-18 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-18 | Novartis Pharmaceuticals Corporation | $7 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-09-17 | Teva Pharmaceuticals USA, Inc. | $2,380 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-17 | Teva Pharmaceuticals USA, Inc. | $121 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-17 | Teva Pharmaceuticals USA, Inc. | $33 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-17 | TG Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-17 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-17 | TG Therapeutics, Inc. | $1 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-16 | Lundbeck LLC | $2,075 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-16 | UCB, Inc. | $20 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-09-15 | Amneal Pharmaceuticals LLC | $1,557 | Honoraria | Cash or cash equivalent | ONGENTYS Drug, NEUROLOGY | 2025 | |
| 2025-09-10 | TG Therapeutics, Inc. | $232 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-10 | SK Life Science, Inc. | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-09 | PFIZER INC. | $4,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-09 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-09 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-08 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-06 | Lundbeck LLC | $667 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $50 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $37 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $35 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $23 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $192 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $124 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $43 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-04 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-04 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-04 | PFIZER INC. | $110 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-04 | Lundbeck LLC | $45 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-03 | UCB, Inc. | $19 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-03 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-02 | Lundbeck LLC | $45 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-02 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-02 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-28 | PFIZER INC. | $76 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-28 | Novartis Pharmaceuticals Corporation | $8 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-08-27 | Otsuka America Pharmaceutical, Inc. | $3,168 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | Alexion Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-08-27 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-27 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-26 | TG Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-08-25 | Biogen, Inc. | $8 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-08-22 | Otsuka America Pharmaceutical, Inc. | $255 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-20 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-20 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-08-19 | Biogen, Inc. | $28 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-08-14 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-14 | Neurocrine BioSciences, Inc. | $5 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-13 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | WAINUA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | Amneal Pharmaceuticals LLC | $4 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-08-08 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-07 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-07 | Novartis Pharmaceuticals Corporation | $8 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | Lundbeck LLC | $60 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-05 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-05 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-30 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-30 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-07-29 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-29 | CATALYST PHARMACEUTICALS, INC. | $15 | Food and Beverage | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2025 | |
| 2025-07-28 | Biogen, Inc. | $9 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-07-28 | Amneal Pharmaceuticals LLC | $6 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-07-23 | Mallinckrodt Hospital Products Inc. | $20 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-07-23 | Novartis Pharmaceuticals Corporation | $7 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-07-22 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-07-22 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | PFIZER INC. | $4 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-16 | UCB, Inc. | $28 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-07-16 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-16 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-15 | UCB, Inc. | $950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Nayzilam Drug, Neurology | 2025 | |
| 2025-07-15 | TG Therapeutics, Inc. | $31 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-07-02 | Axsome Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | Sunosi Drug, Neurology | 2025 | |
| 2025-07-02 | Novartis Pharmaceuticals Corporation | $7 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-07-01 | Biogen, Inc. | $18 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-06-26 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $652 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-24 | TG Therapeutics, Inc. | $3,107 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BRIUMVI Drug, Immunology | 2025 |
The latest 200 records of 2,670.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Sumter, SC, county Sumter County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Sumter, SC | County Sumter County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 43,053 | 104,725 | 5,296,225 |
| Population, 2020 census P1 | 43,463 | 105,556 | 5,118,425 |
| Median age B01002 | 33.6 | 38.0 | 40.2 |
| Under 18 B01001 | 26.0% | 23.7% | 21.4% |
| 65 and over B01001 | 17.6% | 17.8% | 18.9% |
| Households B11001 | 16,081 | 41,083 | 2,117,989 |
| Foreign born B05002 | 4.9% | 3.0% | 5.8% |
| Median household income B19013 | $55,592 | $56,693 | $69,324 |
| Median family income B19113 | $75,302 | $72,914 | $86,707 |
| Per capita income B19301 | $29,338 | $30,466 | $39,236 |
| Poverty rate B17001 | 16.7% | 16.6% | 14.1% |
| Unemployment rate B23025 | 6.6% | 6.9% | 4.9% |
| Civilian labor force B23025 | 17,146 | 44,264 | 2,560,429 |
| Mean commute (minutes) B08013 | 19.6 | 23.0 | 25.6 |
| Bachelor's degree or higher B15003 | 28.7% | 23.5% | 32.1% |
| Housing units B25001 | 18,739 | 47,582 | 2,443,039 |
| Owner-occupied B25003 | 57.2% | 68.1% | 71.9% |
| Renters B25003 | 42.8% | 31.9% | 28.1% |
| Median home value B25077 | $199,100 | $165,300 | $259,000 |
| Median gross rent B25064 | $1,076 | $1,057 | $1,180 |
| White, not Hispanic B03002 | 38.4% | 43.6% | 61.9% |
| Black B03002 | 46.1% | 45.8% | 24.6% |
| Hispanic or Latino B03002 | 7.1% | 4.4% | 7.4% |
| Asian B03002 | 2.8% | 1.4% | 1.7% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sumter, SC.
Comments